TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys
The cytoplasmic TRIM5α proteins of certain mammalian lineages efficiently recognize the incoming capsids of particular retroviruses and potently restrict infection in a species-specific manner. Successful retroviruses have evolved capsids that are less efficiently recognized by the TRIM5α proteins of the natural hosts. To address whether TRIM5α contributes to the outcome of retroviral infection in a susceptible host species, we investigated the impact of TRIM5 polymorphisms in rhesus monkeys on the course of a simian immunodeficiency virus (SIV) infection. Full-length TRIM5α cDNAs were derived from each of 79 outbred monkeys and sequenced. Associations were explored between the expression of particular TRIM5 alleles and both the permissiveness of cells to SIV infection in vitro and clinical sequelae of SIV infection in vivo. Natural variation in the TRIM5α B30.2(SPRY) domain influenced the efficiency of SIVmac capsid binding and the in vitro susceptibility of cells from the monkeys to SIVmac infection. We also show the importance in vivo of the interaction of SIVmac with different allelic forms of TRIM5, demonstrating that particular alleles are associated with as much as 1.3 median log difference in set-point viral loads in SIVmac-infected rhesus monkeys. Moreover, these allelic forms of TRIM5 were associated with the extent of loss of central memory (CM) CD4+ T cells and the rate of progression to AIDS in the infected monkeys. These findings demonstrate a central role for TRIM5α in limiting the replication of an immunodeficiency virus infection in a primate host.
Vyšlo v časopise:
TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys. PLoS Pathog 6(1): e32767. doi:10.1371/journal.ppat.1000738
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000738
Souhrn
The cytoplasmic TRIM5α proteins of certain mammalian lineages efficiently recognize the incoming capsids of particular retroviruses and potently restrict infection in a species-specific manner. Successful retroviruses have evolved capsids that are less efficiently recognized by the TRIM5α proteins of the natural hosts. To address whether TRIM5α contributes to the outcome of retroviral infection in a susceptible host species, we investigated the impact of TRIM5 polymorphisms in rhesus monkeys on the course of a simian immunodeficiency virus (SIV) infection. Full-length TRIM5α cDNAs were derived from each of 79 outbred monkeys and sequenced. Associations were explored between the expression of particular TRIM5 alleles and both the permissiveness of cells to SIV infection in vitro and clinical sequelae of SIV infection in vivo. Natural variation in the TRIM5α B30.2(SPRY) domain influenced the efficiency of SIVmac capsid binding and the in vitro susceptibility of cells from the monkeys to SIVmac infection. We also show the importance in vivo of the interaction of SIVmac with different allelic forms of TRIM5, demonstrating that particular alleles are associated with as much as 1.3 median log difference in set-point viral loads in SIVmac-infected rhesus monkeys. Moreover, these allelic forms of TRIM5 were associated with the extent of loss of central memory (CM) CD4+ T cells and the rate of progression to AIDS in the infected monkeys. These findings demonstrate a central role for TRIM5α in limiting the replication of an immunodeficiency virus infection in a primate host.
Zdroje
1. HatziioannouT
Perez-CaballeroD
YangA
CowanS
BieniaszPD
2004 Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α. Proc Natl Acad Sci U S A 101 10774 10779
2. KeckesovaZ
YlinenLMJ
TowersGJ
2004 The human and African green monkey TRIM5α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101 10780 10785
3. YapM
NisoleS
LynchC
StoyeJ
2004 Trim5α protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101 10786 10791
4. StremlauM
OwensCM
PerronMJ
KiesslingM
AutissierP
2004 The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 848 853
5. PerronMJ
StremlauM
SongB
UlmW
MulliganRC
2004 TRIM5α mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A 101 11827 11832
6. RichardsonMW
CarrollRG
StremlauM
KorokhovN
HumeauLM
2008 Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol 82 11117 11128
7. SongB
GoldB
O'HuiginC
JavanbakhtH
LiX
2005 The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol 79 6111 6121
8. NewmanRM
HallL
ConnoleM
ChenGL
SatoS
2006 Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc Natl Acad Sci U S A 103 19134 19139
9. WilsonSJ
WebbBL
MaplankaC
NewmanRM
VerschoorEJ
2008 Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J Virol 82 7243 7247
10. OurmanovI
BilskaM
HirschVM
MontefioriDC
2004 Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques. J Virol 74 2960 2965
11. PolacinoP
StallardV
KlanieckiJE
MontefioriDC
LangloisAJ
1999 Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J Virol 73 618 630
12. YasutomiY
ReimannKA
LordCI
MillerMD
LetvinNL
1993 Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 67 1707 1711
13. PalR
VenzonD
LetvinNL
SantraS
Montefiori
2002 ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J Virol 76 292 302
14. GoldsteinS
BrownCR
DehghaniH
LifsonJD
HirschVM
2000 Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo replication. J Virol 74 9388 9395
15. BrennanG
KozyrevY
HuSL
2009 TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc Natl Acad Sci U S A 105 3569 3574
16. NewmanRM
HallL
KirmaierA
PozziLA
PeryE
2008 Evolution of a TRIM5-CypA splice isoform in old world monkeys. PLoS Pathog 4 e1000003
17. VirgenCA
KratovacZ
BieniaszPD
HatziioannouT
2008 Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A 105 3563 3568
18. WilsonSJ
WebBL
YlinenLM
VerschoorE
HeeneyJL
2008 Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A 105 3557 3562
19. StremlauM
PerronM
LeeM
LiY
SongB
2006 Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 103 5514 5519
20. PerronMJ
StremlauM
LeeM
JavanbakhtH
SongB
2007 The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol 81 2138 2148
21. JavanbakhtH
YuanW
YeungDF
SongB
Diaz-GrifferoF
2006 Characterization of TRIM5alpha trimerization and its contribution to human immunodeficiency virus capsid binding. Virology 353 234 246
22. GanserBK
LiS
KlishkoVY
FinchJT
SundquistWI
1999 Assembly and analysis of conical models for the HIV-1 core. Science 283 80 83
23. Diaz-GrifferoF
KarA
LeeM
StremlauM
PoeschlaE
2007 Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp. Virology 369 400 410
24. LoffredoJT
BeanAT
BealDR
LeónEJ
MayGE
2008 Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication. J Virol 82 1723 1738
25. ManessNJ
YantLJ
ChungC
LoffredoJT
FriedrichTC
2008 Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques. J Virol 82 5245 5254
26. MothéBR
WeinfurterJ
WangC
RehrauerW
WilsonN
2003 Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 77 2736 2740
27. KaslowRA
CarringtonM
AppleR
ParkL
MuñozA
1996 Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature medicine 2 405 411
28. FellayJ
ShiannaKV
GeD
ColomboS
2007 A whole-genome association study of major determinants for host control of HIV-1. Science 317 944 947
29. MartinMP
GaoX
LeeJH
NelsonGW
DetelsR
2002 Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genetics 31 429 434
30. DeanM
CarringtonM
WinklerC
HuttleyGA
SmithMW
1996 Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273 1856 1862
31. HuangY
PaxtonWA
WolinskySM
NeumannAU
ZhangL
1996 The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Medicine 2 1240 1243
32. SmithMW
DeanM
CarringtonM
WinklerC
HuttleyGA
1997 Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277 959 965
33. MischeCC
JavanbakhtH
SongB
Diaz-GrifferoF
StremlauM
2005 Retroviral restriction factor TRIM5alpha is a trimer. J Virol 79 14446 14450
34. KarAK
Diaz-GrifferoF
LiY
LiX
SodroskiJ
2008 Biochemical and biophysical characterization of a chimeric TRIM21-TRIM5alpha protein. J Virol 82 11669 11681
35. LangelierCR
SandrinV
EckertDM
ChristensenDE
ChandrasekaranV
2008 Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J Virol 82 11682 11694
36. LiX
SodroskiJ
2008 The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association. J Virol 82 11495 11502
37. Perez-CaballeroD
HatziioannouT
YangA
CowanS
BieniaszPD
2005 Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J Virol 79 8969
38. JavanbakhtH
Diaz-GrifferoF
StremlauM
SiZ
SodroskiJ
2005 The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J Biol Chem 280 26933 26940
39. TorimiroJN
JavanbakhtH
Diaz-GrifferoF
KimJ
CarrJK
2009 A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology Epub ahead of print
40. JavanbakhtH
AnP
GoldB
PetersenDC
O'HuiginC
2006 Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection. Virology 353 234 246
41. SawyerSL
WuLI
AkeyJM
EmermanM
MalikHS
2006 High-frequency persistence of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Curr Biol 16 95 100
42. SpeelmonEC
Livingston-RosanoffD
LiSS
VuQ
BuiJ
GeraghtyDE
2006 Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J Virol 80 2463 2471
43. van ManenD
RitsMA
BeugelingC
van DortK
SchuitemakerH
2008 The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection. PLoS Pathog 4 e18
44. GoldschmidtV
BleiberG
MayM
MartinezR
OrtizM
2006 Role of common human TRIM5alpha variants in HIV-1 disease progression. Retrovirology 22 54 61
45. KaurA
GrantRM
MeansRE
McClureH
FeinbergM
1998 Diverse Host Responses and Outcomes following Simian Immunodeficiency Virus SIVmac239 Infection in Sooty Mangabeys and Rhesus Macaques. J Virol 72 9597 9611
46. SunY
PermarSR
BuzbyAP
LetvinNL
2007 Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection. J Immunol 81 8009 8015
47. LetvinNL
MascolaJR
SuY
GorgoneDA
BuzbyAP
2006 Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys. Science 312 1530 1533
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 1
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils
- CD8+ T Cell Control of HIV—A Known Unknown
- Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
- The Deadly Chytrid Fungus: A Story of an Emerging Pathogen